CombiMatrix, Pathology in Prenatal Test Alliance

Nov 06, 2012

|

NEW YORK (GenomeWeb News) – CombiMatrix today said that Pathology, Inc. will market and distribute its chromosomal microarray tests for "products of conception" testing in designated areas in the US.

Products of conception testing enables physicians to better determine if there is a genetic cause behind a miscarriage or multiple events, said Irvine, Calif.-based CombiMatrix.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

Same Old Error

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

Own Merits

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Back to Neanderthals

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

PNAS Papers on Small Molecule From Soil Bacteria, Circulating Tumor Cell Chip, More

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.

Featured White Papers

White Paper: Using Single-Cell Multiomics to Reveal New Insights Into Uveal Melanoma Evolution and Therapeutic Resistance

Modular DNA Assembly of PIK3CA Using Acoustic Liquid Transfer in Nanoliter Volumes

Expanded Droplet Digital PCR Multiplexing Capability Using Two Different Strategies

Decoding Carrier Screening

Aug

13

Featured Webinar

Single-Cell and Spatial Transcriptomic Profiling of the Septic Kidney

This webinar will discuss a study that combined single-cell gene expression and spatial gene expression to understand the evolution of sepsis in the kidney at the cellular and molecular level.

Menu

CombiMatrix, Pathology in Prenatal Test Alliance

To read the full story....

Breaking News

Sequencing Study Reveals Role of RIPOR2 Mutation in Adult-Onset Hearing Loss

Progenity Asks Court to Declare Non-Infringement of Natera Patents

FDA Issues New Guidance for SARS-CoV-2 Pooled Sample Testing

Computational Tools Help Predict Efficiency, Outcomes of Base Editors

Exome Analysis of Southwestern American Indians Highlights Metabolic Disease-Linked Variants

Advanced Biological Laboratories Gets CE Mark for SARS-CoV-2 qPCR Assay